Market Cap 5.57B
Revenue (ttm) 8.87B
Net Income (ttm) 635.00M
EPS (ttm) N/A
PE Ratio 15.40
Forward PE 16.74
Profit Margin 7.16%
Debt to Equity Ratio 0.27
Volume 6,210,400
Avg Vol 4,330,838
Day's Range N/A - N/A
Shares Out 364.75M
Stochastic %K 80%
Beta 1.25
Analysts Sell
Price Target $15.83

Company Profile

NOV Inc. designs, constructs, manufactures, and sells systems, components, and products for oil and gas drilling and production, and industrial and renewable energy sectors in the United States and internationally. It operates in two segments, Energy Equipment, and Energy Products and Services. The company provides solids control and waste management equipment and services; managed pressure drilling, wired drill pipe, and tubular inspection and coating services; precision-engineered drill pipe a...

Industry: Oil & Gas Equipment & Services
Sector: Energy
Phone: 346 223 3000
Website: www.nov.com
Address:
10353 Richmond Avenue, Houston, United States
PrivateProfiteer
PrivateProfiteer Nov. 15 at 12:55 AM
$NOV: The current market context shows a last close of $15.27, with an RSI of 66.67 indicating that the stock is approaching overbought territory. The 30-day moving average (MA30) at $14.07 and the 50-day moving average (MA50) at $13.69 suggest a bullish trend, as the price is above both MAs. The 60-day high of $16.00 provides a resistance level, while the low of $12.09 indicates solid support. Directional bias leans bullish, but caution is warranted due to the elevated RSI. Suggested entry could be at $15.10, slightly below the last close to confirm buying interest. Set a stop loss at $14.75 to manage risk. Target 1 can be set at $16.00 (60D high), while Target 2 could be at $16.50, allowing for potential upside if momentum continues. Monitor the RSI for signs of reversal and adjust the plan accordingly. https://privateprofiteers.com
0 · Reply
Joby099
Joby099 Nov. 14 at 4:01 PM
0 · Reply
chessNwine
chessNwine Nov. 14 at 4:00 PM
$NOV Daily. After a volatile week, oil looks to close out on a strong note. Oil services names like NOV impress by not budging into the crude oil price swings. Strong, smooth chart.
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 14 at 4:28 AM
$NOV: The current market context shows a last close of $15.27, with an RSI of 66.67 indicating that the stock is approaching overbought territory. The 30-day moving average (MA30) at $14.07 and the 50-day moving average (MA50) at $13.69 suggest a bullish trend, as the price is above both MAs. The 60-day high of $16.00 provides a resistance level, while the low of $12.09 indicates solid support. Directional bias leans bullish, but caution is warranted due to the elevated RSI. Suggested entry could be at $15.10, slightly below the last close to confirm buying interest. Set a stop loss at $14.75 to manage risk. Target 1 can be set at $16.00 (60D high), while Target 2 could be at $16.50, allowing for potential upside if momentum continues. Monitor the RSI for signs of reversal and adjust the plan accordingly. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 13 at 2:34 AM
$NOV: The current market context shows a last close of $15.69, with an RSI of 74.44 indicating overbought conditions. This suggests a potential pullback may occur soon. The 30-day moving average (MA30) is at $13.94 and the 50-day moving average (MA50) is at $13.60, both indicating strong support levels below the current price. The 60-day high of $16.00 is just above the last close, while the low of $12.09 provides a solid range for potential price movement. Directional bias leans bearish due to the high RSI, suggesting a correction may be imminent. Suggested entry point is around $15.50, with a stop loss set at $15.20 to limit potential losses. Target 1 is $14.50, aligning with the MA30, and Target 2 is $14.00, which is a psychological support level. Monitor price action closely for confirmation of the bearish bias before entering. https://privateprofiteers.com
0 · Reply
JarvisFlow
JarvisFlow Nov. 12 at 9:01 PM
Citigroup has adjusted their stance on NOV ( $NOV ), setting the rating to Neutral with a target price of 14 → 16.
0 · Reply
dragon_heart
dragon_heart Nov. 12 at 6:49 AM
$HST $WDC $NOV $SU 11/12/2025 stocks to trade on the short side. https://x.com/dragonheart_kh/status/1988495827757629947?s=20
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 12 at 2:10 AM
$NOV: The current market context shows a last close of $15.69, with an RSI of 74.44 indicating overbought conditions. This suggests a potential pullback may occur soon. The 30-day moving average (MA30) is at $13.94 and the 50-day moving average (MA50) is at $13.60, both indicating strong support levels below the current price. The 60-day high of $16.00 is just above the last close, while the low of $12.09 provides a solid range for potential price movement. Directional bias leans bearish due to the high RSI, suggesting a correction may be imminent. Suggested entry point is around $15.50, with a stop loss set at $15.20 to limit potential losses. Target 1 is $14.50, aligning with the MA30, and Target 2 is $14.00, which is a psychological support level. Monitor price action closely for confirmation of the bearish bias before entering. https://privateprofiteers.com
0 · Reply
JarvisFlow
JarvisFlow Nov. 11 at 3:28 PM
Barclays has updated their rating for NOV ( $NOV ) to Underweight with a price target of 13.
0 · Reply
BubbleBoyLippmann
BubbleBoyLippmann Nov. 9 at 3:12 AM
$NOV Chart looks sexy. Institution positions healthy. Tempting to get in for long term.
0 · Reply
Latest News on NOV
NOV Inc. (NOV) Q3 2025 Earnings Call Transcript

Oct 28, 2025, 2:51 PM EDT - 17 days ago

NOV Inc. (NOV) Q3 2025 Earnings Call Transcript


These 3 Beaten-Down Oil Stocks Could Make A Big Comeback

Oct 15, 2025, 8:18 AM EDT - 4 weeks ago

These 3 Beaten-Down Oil Stocks Could Make A Big Comeback

NOA RNGR


NOV Announces Third Quarter 2025 Earnings Conference Call

Sep 29, 2025, 6:30 AM EDT - 6 weeks ago

NOV Announces Third Quarter 2025 Earnings Conference Call


NOV Declares Regular Quarterly Dividend

Aug 14, 2025, 6:30 AM EDT - 3 months ago

NOV Declares Regular Quarterly Dividend


NOV Inc. (NOV) Q2 2025 Earnings Conference Call Transcript

Jul 29, 2025, 5:08 PM EDT - 3 months ago

NOV Inc. (NOV) Q2 2025 Earnings Conference Call Transcript


NOV Reports Second Quarter 2025 Results

Jul 28, 2025, 5:45 PM EDT - 3 months ago

NOV Reports Second Quarter 2025 Results


NOV: Growth Proposition Intact Despite Near-Term Headwind

Jul 9, 2025, 12:47 AM EDT - 4 months ago

NOV: Growth Proposition Intact Despite Near-Term Headwind


NOV Announces Second Quarter 2025 Earnings Conference Call

Jun 27, 2025, 6:30 AM EDT - 5 months ago

NOV Announces Second Quarter 2025 Earnings Conference Call


NOV Inc. (NOV) Q1 2025 Earnings Call Transcript

Apr 29, 2025, 12:44 PM EDT - 7 months ago

NOV Inc. (NOV) Q1 2025 Earnings Call Transcript


NOV Reports First Quarter 2025 Results

Apr 28, 2025, 5:45 PM EDT - 7 months ago

NOV Reports First Quarter 2025 Results


NOV Announces Key Leadership Changes

Mar 19, 2025, 5:00 PM EDT - 8 months ago

NOV Announces Key Leadership Changes


NOV: Shareholder Returns Have Likely Peaked For Now

Feb 7, 2025, 3:21 PM EST - 10 months ago

NOV: Shareholder Returns Have Likely Peaked For Now


NOV Inc. (NOV) Q4 2024 Earnings Call Transcript

Feb 5, 2025, 3:12 PM EST - 10 months ago

NOV Inc. (NOV) Q4 2024 Earnings Call Transcript


NOV Reports Fourth Quarter and Full-Year 2024 Earnings

Feb 4, 2025, 5:45 PM EST - 10 months ago

NOV Reports Fourth Quarter and Full-Year 2024 Earnings


NOV Appoints Chris Kendall to the Board of Directors

Dec 16, 2024, 6:30 AM EST - 11 months ago

NOV Appoints Chris Kendall to the Board of Directors


The Big 3: DJT, JD, NOV

Dec 5, 2024, 12:27 PM EST - 1 year ago

The Big 3: DJT, JD, NOV

DJT JD


NOV Inc. (NOV) Q3 2024 Earnings Call Transcript

Oct 25, 2024, 2:55 PM EDT - 1 year ago

NOV Inc. (NOV) Q3 2024 Earnings Call Transcript


NOV Reports Third Quarter 2024 Results

Oct 24, 2024, 5:45 PM EDT - 1 year ago

NOV Reports Third Quarter 2024 Results


NOV Announces Third Quarter 2024 Earnings Conference Call

Sep 23, 2024, 6:30 AM EDT - 1 year ago

NOV Announces Third Quarter 2024 Earnings Conference Call


NOV Inc. (NOV) Q2 2024 Earnings Call Transcript

Jul 26, 2024, 3:27 PM EDT - 1 year ago

NOV Inc. (NOV) Q2 2024 Earnings Call Transcript


NOV Reports Second Quarter 2024 Results

Jul 25, 2024, 6:00 PM EDT - 1 year ago

NOV Reports Second Quarter 2024 Results


6 Stocks That Have Come Too Far, Too Fast

Jul 22, 2024, 11:23 AM EDT - 1 year ago

6 Stocks That Have Come Too Far, Too Fast

BJRI COOP CUBI MXL SAH


NOV Announces Second Quarter 2024 Earnings Conference Call

Jun 21, 2024, 6:30 AM EDT - 1 year ago

NOV Announces Second Quarter 2024 Earnings Conference Call


NOV Inc. (NOV) Q1 2024 Earnings Call Transcript

Apr 26, 2024, 3:50 PM EDT - 1 year ago

NOV Inc. (NOV) Q1 2024 Earnings Call Transcript


Bullish on NOV

Apr 15, 2024, 1:14 PM EDT - 1 year ago

Bullish on NOV


Arcosa, Inc. Announces Completion of Ameron Acquisition

Apr 9, 2024, 4:15 PM EDT - 1 year ago

Arcosa, Inc. Announces Completion of Ameron Acquisition

ACA


NOV Announces First Quarter 2024 Earnings Conference Call

Mar 26, 2024, 6:30 AM EDT - 1 year ago

NOV Announces First Quarter 2024 Earnings Conference Call


NOV Inc. (NOV) Q4 2023 Earnings Call Transcript

Feb 2, 2024, 1:58 PM EST - 1 year ago

NOV Inc. (NOV) Q4 2023 Earnings Call Transcript


NOV Reports Fourth Quarter and Full Year 2023 Earnings

Feb 1, 2024, 5:30 PM EST - 1 year ago

NOV Reports Fourth Quarter and Full Year 2023 Earnings


NOV Inc. (NOV) Q3 2023 Earnings Call Transcript

Oct 27, 2023, 12:37 PM EDT - 2 years ago

NOV Inc. (NOV) Q3 2023 Earnings Call Transcript


NOV Reports Third Quarter 2023 Earnings

Oct 26, 2023, 5:00 PM EDT - 2 years ago

NOV Reports Third Quarter 2023 Earnings


NOV Announces Third Quarter 2023 Earnings Conference Call

Sep 12, 2023, 11:48 AM EDT - 2 years ago

NOV Announces Third Quarter 2023 Earnings Conference Call


NOV Inc. (NOV) Q2 2023 Earnings Call Transcript

Jul 27, 2023, 3:44 PM EDT - 2 years ago

NOV Inc. (NOV) Q2 2023 Earnings Call Transcript


NOV Reports Second Quarter 2023 Earnings

Jul 26, 2023, 5:00 PM EDT - 2 years ago

NOV Reports Second Quarter 2023 Earnings


NOV Announces Second Quarter 2023 Earnings Conference Call

Jun 13, 2023, 6:00 PM EDT - 2 years ago

NOV Announces Second Quarter 2023 Earnings Conference Call


NOV Inc. (NOV) Q1 2023 Earnings Call Transcript

Apr 27, 2023, 4:20 PM EDT - 2 years ago

NOV Inc. (NOV) Q1 2023 Earnings Call Transcript


PrivateProfiteer
PrivateProfiteer Nov. 15 at 12:55 AM
$NOV: The current market context shows a last close of $15.27, with an RSI of 66.67 indicating that the stock is approaching overbought territory. The 30-day moving average (MA30) at $14.07 and the 50-day moving average (MA50) at $13.69 suggest a bullish trend, as the price is above both MAs. The 60-day high of $16.00 provides a resistance level, while the low of $12.09 indicates solid support. Directional bias leans bullish, but caution is warranted due to the elevated RSI. Suggested entry could be at $15.10, slightly below the last close to confirm buying interest. Set a stop loss at $14.75 to manage risk. Target 1 can be set at $16.00 (60D high), while Target 2 could be at $16.50, allowing for potential upside if momentum continues. Monitor the RSI for signs of reversal and adjust the plan accordingly. https://privateprofiteers.com
0 · Reply
Joby099
Joby099 Nov. 14 at 4:01 PM
0 · Reply
chessNwine
chessNwine Nov. 14 at 4:00 PM
$NOV Daily. After a volatile week, oil looks to close out on a strong note. Oil services names like NOV impress by not budging into the crude oil price swings. Strong, smooth chart.
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 14 at 4:28 AM
$NOV: The current market context shows a last close of $15.27, with an RSI of 66.67 indicating that the stock is approaching overbought territory. The 30-day moving average (MA30) at $14.07 and the 50-day moving average (MA50) at $13.69 suggest a bullish trend, as the price is above both MAs. The 60-day high of $16.00 provides a resistance level, while the low of $12.09 indicates solid support. Directional bias leans bullish, but caution is warranted due to the elevated RSI. Suggested entry could be at $15.10, slightly below the last close to confirm buying interest. Set a stop loss at $14.75 to manage risk. Target 1 can be set at $16.00 (60D high), while Target 2 could be at $16.50, allowing for potential upside if momentum continues. Monitor the RSI for signs of reversal and adjust the plan accordingly. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 13 at 2:34 AM
$NOV: The current market context shows a last close of $15.69, with an RSI of 74.44 indicating overbought conditions. This suggests a potential pullback may occur soon. The 30-day moving average (MA30) is at $13.94 and the 50-day moving average (MA50) is at $13.60, both indicating strong support levels below the current price. The 60-day high of $16.00 is just above the last close, while the low of $12.09 provides a solid range for potential price movement. Directional bias leans bearish due to the high RSI, suggesting a correction may be imminent. Suggested entry point is around $15.50, with a stop loss set at $15.20 to limit potential losses. Target 1 is $14.50, aligning with the MA30, and Target 2 is $14.00, which is a psychological support level. Monitor price action closely for confirmation of the bearish bias before entering. https://privateprofiteers.com
0 · Reply
JarvisFlow
JarvisFlow Nov. 12 at 9:01 PM
Citigroup has adjusted their stance on NOV ( $NOV ), setting the rating to Neutral with a target price of 14 → 16.
0 · Reply
dragon_heart
dragon_heart Nov. 12 at 6:49 AM
$HST $WDC $NOV $SU 11/12/2025 stocks to trade on the short side. https://x.com/dragonheart_kh/status/1988495827757629947?s=20
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 12 at 2:10 AM
$NOV: The current market context shows a last close of $15.69, with an RSI of 74.44 indicating overbought conditions. This suggests a potential pullback may occur soon. The 30-day moving average (MA30) is at $13.94 and the 50-day moving average (MA50) is at $13.60, both indicating strong support levels below the current price. The 60-day high of $16.00 is just above the last close, while the low of $12.09 provides a solid range for potential price movement. Directional bias leans bearish due to the high RSI, suggesting a correction may be imminent. Suggested entry point is around $15.50, with a stop loss set at $15.20 to limit potential losses. Target 1 is $14.50, aligning with the MA30, and Target 2 is $14.00, which is a psychological support level. Monitor price action closely for confirmation of the bearish bias before entering. https://privateprofiteers.com
0 · Reply
JarvisFlow
JarvisFlow Nov. 11 at 3:28 PM
Barclays has updated their rating for NOV ( $NOV ) to Underweight with a price target of 13.
0 · Reply
BubbleBoyLippmann
BubbleBoyLippmann Nov. 9 at 3:12 AM
$NOV Chart looks sexy. Institution positions healthy. Tempting to get in for long term.
0 · Reply
JarvisFlow
JarvisFlow Nov. 5 at 4:56 PM
Goldman Sachs has adjusted their stance on NOV ( $NOV ), setting the rating to Sell with a target price of 12 → 14.
0 · Reply
clan
clan Nov. 4 at 11:00 AM
$MNKD Trial enrollment status? 100%? Update incoming... CLOFAZIMINE (CIS) by Mannkind ------------------------------------------- Designations: - Phase 3 ICoN-1 international trials • U.S.A. & Japan & Australia & Korea - Fast Tracked by FDA - Orpan Drug - Qualified Infectious Disease Product - Well tolerated - No significant Adverse Events - Localized treatment (lungs) - Improved patient adherence - Indications for arthritis & CANCERs - Current global mkt $2.3B [2023] {even with the adverse events (AEs) caused by other pharmas' current formulations} ...and coming soon..... - - - Clofazimine DPI Partner with $GSK ? $NOV ? Maybe $MRK ?
0 · Reply
NVDAMillionaire
NVDAMillionaire Nov. 3 at 5:00 PM
$NOV Excellent article that nails exactly where NOV stands right now. So if you want to update your NOV knowledge or get acquainted with NOV, this is a must read. https://beyondspx.com/quote/NOV/analysis/nov-s-dual-engine-of-growth-powering-deepwater-and-international-shale-expansion-nyse-nov
0 · Reply
__SquuezedChronometer_
__SquuezedChronometer_ Nov. 2 at 10:53 AM
Next major retail squeeze candidate right here $NOV $ACDC $IDR $SSSS <
0 · Reply
SuperGreenToday
SuperGreenToday Nov. 1 at 2:45 AM
$NOV Share Price: $14.60 Contract Selected: Feb 20, 2026 $15 Calls Buy Zone: $0.85 – $1.05 Target Zone: $1.54 – $1.88 Potential Upside: 71% ROI Time to Expiration: 111 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
CaptQuint
CaptQuint Oct. 31 at 12:59 PM
$NVOX $NOV Opportunities to load more.
0 · Reply
ZacksResearch
ZacksResearch Oct. 29 at 6:22 PM
$NOV beats on revenue but misses earnings — trouble beneath the surface? Weak oilfield activity and segment underperformance dragged results lower year over year, despite the top-line beat. See the full Q3 breakdown here 👉 https://www.zacks.com/stock/news/2780521/nov-q3-earnings-miss-revenues-beat-estimates-both-decrease-yy?cid=sm-stocktwits-2-2780521-teaser-18414&ADID=SYND_STOCKTWITS_TWEET_2_2780521_TEASER_18414
0 · Reply
ZacksResearch
ZacksResearch Oct. 29 at 5:22 PM
$NOV Q3 earnings miss — what's dragging it down? 🤔 NOV reported a Q3 EPS of 11 cents, missing the Zacks Consensus Estimate of 24 cents, mainly due to the underperformance of the Energy Products and Services segment. Despite this, total revenues of $2.2 billion beat estimates by 1.9% 📉. Complete analysis here 👉 https://www.zacks.com/stock/news/2780521/nov-q3-earnings-miss-revenues-beat-estimates-both-decrease-yy?cid=sm-stocktwits-2-2780521-body-18320&ADID=SYND_STOCKTWITS_TWEET_2_2780521_BODY_18320
0 · Reply
Bullish_Trader555
Bullish_Trader555 Oct. 29 at 11:44 AM
$NESR Saudi Aramco Awards Multi-Billion Dollar Unconventional Contract to NESR $SPY $NOV $OIS
0 · Reply
Estimize
Estimize Oct. 27 at 11:33 PM
$NOV reported 0.11 EPS and 2,176 revenue for Q3. http://www.estimize.com/intro/nov?chart=historical&metric_name=eps&utm_content=NOV&utm_med
0 · Reply
bagump23
bagump23 Oct. 27 at 10:29 PM
$NOV without the one time write down would have been .29 per share earnings
0 · Reply
DonCorleone77
DonCorleone77 Oct. 27 at 9:58 PM
$NOV NOV Inc. reports Q3 EPS 11c, consensus 25c -- Q3 revenue $2.18B, consensus $2.14B. -- Sees Q4 revenue down 5%-7% y/y, consensus $2.16B. -- Sees Q4 adjusted EBITDA $230M-$260M. -- Appoints Jose Bayardo to board of directors.
0 · Reply